Subscribe to Daily Review - your favourite M&A deals update.

MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image KARUNA THERAPEUTICS
KARUNA THERAPEUTICS

KARUNA THERAPEUTICS

Summary

Karuna Therapeutics is a clinical-stage biopharmaceutical company.

Deals Overview

Total Deals2
Valued Deals2
Total Value£ 10.19 B
Avg. Deal Size£ 5.09 B

Market Context

Senior Management

  • Andrew Miller

    Andrew Miller

    President and CEO

  • Bill Meury

    Bill Meury

    President and CEO

  • Alexis Smith

    Alexis Smith

    Vice President, Corporate Affairs and Investor Relations

Sort

as

alexis smith

Vice President, Corporate Affairs and Investor Relations at KARUNA THERAPEUTICS

Manager

1

Deal

£ 10.03 B

Total Value

bm

bill meury

President and CEO at KARUNA THERAPEUTICS

Manager

1

Deal

£ 10.03 B

Total Value

am

andrew miller

President and CEO at KARUNA THERAPEUTICS

Manager

1

Deal

£ 153 M

Total Value

Explore dealmakers beyond your search with a free MergerLinks account.

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite